Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
AKT
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
6
12
18
24
30
36
42
48
54
60
MK-2206
/ Merck (MSD)
7-Hydroxystaurosporine
(UCN-01) / National Cancer Institute
uprosertib
(LAE003) / Laekna Therap
ST266
/ Noveome Biotherap
Hocena
(antroquinonol) / Golden Biotechnology
miransertib
(MK-7075) / Merck (MSD)
sonolisib
(PX 866) / Pfizer
ABTL0812
/ Ability Pharma
triciribine phosphate
(PTX-200) / VioQuest, Prescient Therap
SM-020
/ DermBiont
LY2780301
/ Eli Lilly
alirinetide
(GM604) / Genervon
Archexin
(WGI-0201) / Zhejiang Haichang Bio-Tech
CMX-2043
/ Ischemix
IPL344
/ Immunity Pharma
Mychexin
(WGI-0301) / Zhejiang Haichang Bio-Tech
oleandrin
(PBI-05204) / Phoenix Biotech
pifusertib
(TAS-117) / Otsuka
quinacrine
(CBL0102) / Incuron
